CytoDyn Inc. (CYDY)
OTCMKTS
· Delayed Price · Currency is USD
0.320
0.00 (0.00%)
At close: Dec 5, 2025
CytoDyn Employees
CytoDyn had 13 employees as of May 31, 2025. The number of employees increased by 4 or 44.44% compared to the previous year.
Employees
13
Change (1Y)
4
Growth (1Y)
44.44%
Revenue / Employee
n/a
Profits / Employee
-$1,731,231
Market Cap
403.93M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Elite Pharmaceuticals | 68 |
| Glass House Brands | 374 |
| American Oncology Network | 1,914 |
| Northwest Biotherapeutics | 25 |
| Silence Therapeutics | 116 |
| Zomedica | 152 |
| Nuo Therapeutics | 9 |
CytoDyn News
- 4 days ago - CytoDyn Announces Resolution of Class Action Lawsuit - GlobeNewsWire
- 11 days ago - CytoDyn to Present Prolonged Survival Data on Leronlimab in Metastatic Triple-Negative Breast Cancer at the San Antonio Breast Cancer Symposium - GlobeNewsWire
- 4 weeks ago - CytoDyn (CYDY) Secures $30 Million Funding Commitment from Yorkville - GuruFocus
- 4 weeks ago - CytoDyn (CYDY) Secures $30M Funding for Cancer Drug Development - GuruFocus
- 4 weeks ago - CytoDyn secures $30M equity funding commitment - Seeking Alpha
- 4 weeks ago - CytoDyn Secures $30 Million Commitment from Yorkville Advisors - GlobeNewsWire
- 6 weeks ago - Halper Sadeh LLC Encourages CytoDyn Inc. Shareholders to Contact the Firm to Discuss Their Rights - Business Wire
- 2 months ago - CytoDyn to Present at the LD Micro Main Event XIX Investor Conference - GlobeNewsWire